
Non Alcoholic Steatohepatitis Nash Management
MASH/NASH treatment in India with fibrosis staging, hepatology assessment, metabolic risk reduction and specialist follow-up for MASLD-related liver inflammation.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About Non Alcoholic Steatohepatitis Nash Management
MASH treatment in India—the condition previously called non-alcoholic steatohepatitis (NASH)—focuses on metabolic dysfunction-associated steatohepatitis within metabolic dysfunction-associated steatotic liver disease (MASLD). The main goals are to reduce liver inflammation and fibrosis risk while treating obesity, diabetes, dyslipidaemia, hypertension and other metabolic drivers.
Assessment may include liver blood tests, metabolic testing, ultrasound and transient elastography or other non-invasive fibrosis assessment, with specialist imaging or liver biopsy reserved for selected patients when diagnosis or staging remains uncertain. Fibrosis stage is especially important because advanced fibrosis changes prognosis, surveillance and the intensity of follow-up.
Management usually combines sustained weight reduction where appropriate, regular physical activity and aggressive treatment of cardiometabolic risk factors. Specialist-directed drug therapy may be considered for selected patients according to fibrosis stage, comorbidities, medicine availability and current evidence. Patients with advanced fibrosis or cirrhosis need monitoring for portal-hypertension complications and hepatocellular carcinoma. New abdominal swelling, vomiting blood, black stools, confusion or jaundice in a patient with advanced liver disease requires urgent local medical assessment.
Cost in India depends on hepatology consultations, laboratory testing, elastography or other imaging, biopsy when needed, medicines and long-term monitoring. Tertiary centres in India can combine hepatology, endocrinology or diabetes care, nutrition and bariatric or metabolic services where appropriate. Medical Help India can connect international patients with an appropriate healthcare partner to review fibrosis risk, previous investigations and metabolic conditions and provide an individual management estimate.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for Non Alcoholic Steatohepatitis Nash Management
View All Hospitals →Top Doctors for Non Alcoholic Steatohepatitis Nash Management
View All Doctors →Frequently Asked Questions
How much does Non Alcoholic Steatohepatitis Nash Management cost in India?
Cost depends on hepatology consultation, liver and metabolic blood tests, ultrasound and elastography or other fibrosis assessment, biopsy when clinically necessary, medicines and long-term monitoring. Advanced fibrosis or cirrhosis generally requires more intensive surveillance and follow-up.
Which medical reports are useful to have ready for Non Alcoholic Steatohepatitis Nash Management?
Have ready: hepatology or gastroenterology notes, recent liver and metabolic blood tests, ultrasound and elastography results, CT or MRI if performed and any liver-biopsy report. Include weight and metabolic history, diabetes and lipid treatment, alcohol history, current medicines and records of any cirrhosis or portal-hypertension complications.
What is the current name for NASH?
NASH is now commonly referred to as metabolic dysfunction-associated steatohepatitis (MASH), within metabolic dysfunction-associated steatotic liver disease (MASLD).
Why is liver fibrosis important in MASH?
The amount of fibrosis is a major predictor of liver-related risk and helps determine follow-up intensity and treatment strategy.
Is weight loss part of MASH treatment?
Yes. When overweight or obesity is present, sustained weight reduction and metabolic risk-factor control are central parts of management.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.


